CellCept 250mg

CellCept 250mg contains mycophenolate mofetil, an immunosuppressive medicine used together with other treatments to help prevent rejection of transplanted organs.

Mycophenolate mofetil is converted in the body to mycophenolic acid, which inhibits an enzyme required for the production of certain nucleotides. This reduces the proliferation of activated lymphocytes and suppresses aspects of the immune response involved in organ rejection.

Key Information

• Contains mycophenolate mofetil
• Immunosuppressive medicine
• 250mg strength
• Oral capsule formulation
• Used in transplant medicine
• Requires specialist medical supervision

Active Ingredient

Mycophenolate Mofetil

Strength

250mg

Dosage Form

Capsule

Medical Uses

CellCept is used in combination with other immunosuppressive medicines to help prevent rejection following kidney, heart, or liver transplantation.

Directions for Use

Take only as prescribed by a transplant specialist or qualified healthcare professional. Take the medicine consistently according to the prescribed schedule. Do not stop or change treatment without medical supervision, as inadequate immunosuppression can increase the risk of organ rejection.

Safety Information

Because CellCept suppresses the immune system, it can increase susceptibility to infections and may affect blood cell counts. Regular medical monitoring is generally required.

Mycophenolate mofetil can cause serious fetal harm and is associated with an increased risk of pregnancy loss and congenital abnormalities. Women who could become pregnant require appropriate pregnancy-prevention measures and medical guidance during treatment.

Storage

Store according to the manufacturer’s instructions at room temperature and protect from excessive heat, moisture, and direct sunlight. Keep out of reach of children.